News Room

An op-ed by Chrissy Buteas, HINJ President and Chief Executive Officer. New Prescription Drug Affordability Council must take a balanced approach that helps patients without

by Chrissy Buteas, President and Chief Executive OfficerHealthCare Institute of New Jersey (HINJ) Trenton, October 31, 2024 ― I write in response to your editorial

Trenton, October 24, 2024 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning Assembly

Trenton, October 21, 2024 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning today’s

Trenton, October 11, 2024 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning the

Trenton, October 11, 2024 ― The HealthCare Institute of New Jersey released the following statement concerning the Federal Trade Commission’s (FTC) final Hart-Scott-Rodino (HSR) premerger notification